Position in IMRX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,065,860
+$2,013,160 QoQ
Shares Held
414,000
+4040.0% QoQ
Ownership
0.640%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#16
of 111 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in IMRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LEVIN CAPITAL STRATEGIES, L.P. holds $15,129,090 across 8 Biotechnology names. IMRX ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AURA |
Aura Biosciences, Inc.
|
838,067 | $5,950,275 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
548,965 | $4,397,209 | |
| 3 | IMRX |
Immuneering Corp
This page
|
414,000 | $2,065,860 | |
| 4 | DRTS |
Alpha Tau Medical Ltd.
|
128,594 | $1,617,712 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
46,176 | $672,784 | |
| 6 | EYPT |
EyePoint, Inc.
|
19,000 | $271,700 | |
| 7 | OCUL |
Ocular Therapeutix, Inc
|
10,000 | $98,200 | |
| 8 | PRME |
Prime Medicine, Inc.
|
15,000 | $55,350 |
All Filings in IMRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,065,860 | 414,000 | Shares | Other | 2026-07-31 | |
| 2026-03-31 | $52,700 | 10,000 | Shares | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||